21
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Cladribine Underdosing in Hairy-cell Leukemia: a Cause for Apparent Response Failure

, , &
Pages 365-367 | Published online: 01 Jul 2009

  • Bates, D.W. and Gawande, A.A. (2000) "Error in medicine: what have we learned', Annals of Internal Medicine 132, 763-767.
  • Kohn, L.T., Corrigan, J.M. and Donaldson, M.S. (1999) To Err is Human: Building a Safer Health System (Institute of Medicine, Washington, DC).
  • Leape, L.L. (1994) "Error in medicine". JAMA 272, 1851-1857.
  • Leape, L.L. (2000) "Institute of Medicine medical error figures are not exaggerated", JAMA 284, 95-97.
  • Piro, L.D. and Golde, D.W. (2001) "Hairy cell leukemia", In: Haskell, C.M., ed, Cancer Treatment V (Saunders, Philadelphia, PA).
  • Saven, A. and Piro, L.D. (1994) "Drug therapy: newer purine analogues for the treatment of hairy cell leukemia", New England Journal of Medicine 330, 691-697.
  • Piro, L.D., Carrera, C.J., Carson, D.A. and B, E. (1990) "Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine", New England Journal of Medicine 322, 1117-1121.
  • Estey, E.H., Kurzrock, R., Kantarjian, H.M., O'Brien, S.M., McCreide, K.B., Beran, M., Koller, C., Keating, M.J., Hirsch-Ginsberg, C. and Huh, Y.O. (1992) "Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)", Blood 79, 882-887
  • Tollman, M.S., Hakimian, D., Rademaker A.W., Zanzig, C., Wollins, E., Rose, E. and Peterson, L.C. (1996) "Relapse of hairy cell leukemia after 2-chlorodeoxyadenosien: long-term follow-up of the Northwestern University experience", Blood 88, 1954-1959.
  • Hoffman, M.A., Janson, D., Rose, E. and R, K.R. (1997) "Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up", Journal of Clinical Oncology 15, 1138-1142.
  • Lauria, R. Rondelli, D., Zinzani, P.L., Boccchia, M., Marotta, G., Salvucci, M., Raspadori, D., Ventura, M.A., Birtolo, S., Forconi, F. and Tura, S. (1997) "Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey", Leukemia 11, 629-632.
  • Robak, T., Blasinska-Morawiec, M., Krykowski, E., Kasznicki, M., Pluzanska, A., Potemski, P., Hellmann, A., Zaucha, J.M., Lewandowski, K., Dmoszynska, A., Hansz, J., Komarnicki, M., Konopka, L., Durzynski, T., Ceglarek, B., Sikorska, A., Kotlarek-Haus, S., Mazur, G., Urasinski, I., Zdziarska, B., Maj, S., Kopec, I., Skotnicki, A.B., Dwilewicz-Trojaczek, J., Kuratowska, Z. and Grieb, P. (1996) "Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lympohocytic leukemia", Leukemia and Lymphoma 22, 509-514.
  • Damasio, E.E., Resegotti, L., Masoudi, B., Bruni, R., Cerri R., Isaza, A., Clavio, M., Risso, M., Spriano, M. and Truini, M. (1998) "Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia", Recenti Progressi in Medicina 89, 68-73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.